The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
Syrian rebels have reportedly detonated car bombs and launched more than 150 rockets in a major counter attack from eastern Aleppo.
The 48-year-old mother-of-two plummeted to her death during a South African holiday when a gust flipped over the basket.
If you've ever wondered what the world looks like through the eyes of a child, look no further than the Instagram feed Things I have drawn.